Showing 2031 - 2040 of 3137 for "Pharmaceuticals and life sciences" with applied filters
05 March 2024 by DPS Parmar (Special Counsel)
Edwin Drake and Mamadou Ngulo Konare have one thing in common: both struck energy gold from Mother Earth.
28 February 2024 by Yuen Law - Singapore : by Tris Xavier
Singapore High Court clarifies prospective consent for disposition of property under the Insolvency, Restructuring and Dissolution Act (“IRDA”) 2018 prior to a bankruptcy order
12 February 2024 by DPS Parmar (Special Counsel)
Biofuels are closely associated with living material. They are different from the traditional first-generation biofuels obtained from long-dead organic matter.
02 February 2024 by Lee & Ko
On January 25, 2024, the Korea Fair Trade Commission (KFTC) proposed amendments (Amendments) to the Monopoly Regulation and Fair Trade Act (MRFTA) were approved by the National Assembly of Korea.
29 January 2024 by DPS Parmar (Special Counsel)
The three tenets of a patent grant are possession, disclosure, and claims of invention.
16 January 2024 by Manisha Singh (Partner) & Vaneet Kaur (Managing Associate)
The exclusive right of a patentee to stop others from making or using their invention for a defined period is balanced by the obligation to disclose the invention in detail.
08 January 2024 by AnJie Broad Law Firm
RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH
05 January 2024 by Ray SHI, Claire XU
Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).
04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
03 January 2024 by Hui Ye Law Firm - China
Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
